Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

214 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II trial evaluating the long-term efficacy and peripheral sensory neuropathy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancer.
Hata T, Uemura M, Danno K, Yoshioka S, Matsuda C, Kagawa Y, Shingai T, Suzuki Y, Tei M, Tanida T, Komori T, Okamura S, Ota H, Takemoto H, Ogino T, Miyoshi N, Yamamoto H, Murata K, Doki Y, Eguchi H. Hata T, et al. Among authors: danno k. Sci Rep. 2024 Nov 2;14(1):26434. doi: 10.1038/s41598-024-73222-0. Sci Rep. 2024. PMID: 39488510 Free PMC article. Clinical Trial.
Interim analysis of a phase II trial evaluating the safety and efficacy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancer.
Danno K, Hata T, Tamai K, Fujie Y, Ide Y, Kim HM, Ohnishi T, Morita S, Yoshioka S, Kudo T, Nishimura J, Matsuda C, Akamatsu H, Mizushima T, Nezu R, Doki Y, Mori M; Multi-Center Clinical Study Group of Osaka; Colorectal Cancer Treatment Group (MCSGO). Danno K, et al. Cancer Chemother Pharmacol. 2017 Oct;80(4):777-785. doi: 10.1007/s00280-017-3419-1. Epub 2017 Aug 19. Cancer Chemother Pharmacol. 2017. PMID: 28825216 Clinical Trial.
Efficacy of Negative Pressure Wound Therapy Followed by Delayed Primary Closure for Abdominal Wounds in Patients with Lower Gastrointestinal Perforations: Multicenter Prospective Study.
Ota H, Danno K, Ohta K, Matsumura T, Komori T, Okamura S, Okano M, Ogawa A, Tamagawa H, Uemura M, Matsuda C, Mizushima T, Yamamoto H, Nezu R, Doki Y, Eguchi H. Ota H, et al. Among authors: danno k. J Anus Rectum Colon. 2020 Jul 30;4(3):114-121. doi: 10.23922/jarc.2019-043. eCollection 2020. J Anus Rectum Colon. 2020. PMID: 32743113 Free PMC article.
[Analysis of Chemotherapy with Trastuzumab in Advanced Gastric Cancer].
Kawada J, Nakatsuka R, Motoori M, Miyazaki S, Danno K, Kubota M, Matsuda C, Nishikawa K, Fujitani K, Iwase K, Tsujinaka T, Tanaka Y. Kawada J, et al. Among authors: danno k. Gan To Kagaku Ryoho. 2015 Nov;42(12):2091-3. Gan To Kagaku Ryoho. 2015. PMID: 26805274 Japanese.
Benefits of using a self-expandable metallic stent as a bridge to surgery for right- and left-sided obstructive colorectal cancers.
Morita S, Yamamoto K, Ogawa A, Naito A, Mizuno H, Yoshioka S, Matsumura T, Ohta K, Suzuki R, Matsuda C, Hata T, Nishimura J, Mizushima T, Doki Y, Mori M; Clinical Study Group of Osaka University (CSGO), Colorectal Group. Morita S, et al. Surg Today. 2019 Jan;49(1):32-37. doi: 10.1007/s00595-018-1701-4. Epub 2018 Aug 13. Surg Today. 2019. PMID: 30105529
Impact of the COVID-19 pandemic on colorectal cancer surgery in Japan: Clinical Study Group of Osaka University-A multicenter retrospective study.
Miyo M, Mizushima T, Nishimura J, Hata T, Tei M, Miyake Y, Kagawa Y, Noura S, Ikenaga M, Danno K, Ogawa A, Chinen Y, Hata T, Miyoshi N, Takahashi H, Uemura M, Yamamoto H, Murata K, Doki Y, Eguchi H; Clinical Study Group of Osaka University Colorectal Group. Miyo M, et al. Among authors: danno k. Ann Gastroenterol Surg. 2022 Aug 20;7(1):121-30. doi: 10.1002/ags3.12616. Online ahead of print. Ann Gastroenterol Surg. 2022. PMID: 36247513 Free PMC article.
Lymph node metastasis in T1 colorectal cancer: Risk factors and prediction model.
Fujino S, Miyoshi N, Kitakaze M, Yasui M, Ohue M, Osawa H, Ide Y, Sueda T, Tei M, Takeda T, Danno K, Suzuki Y, Noura S, Ohshima K, Morii E, Takahashi H, Uemura M, Yamamoto H, Murata K, Doki Y, Eguchi H; Clinical Study Group of Osaka University, Colorectal Cancer Treatment Group (CSGOCG). Fujino S, et al. Among authors: danno k. Oncol Lett. 2023 Mar 28;25(5):191. doi: 10.3892/ol.2023.13776. eCollection 2023 May. Oncol Lett. 2023. PMID: 37065780 Free PMC article.
Clinical outcomes of neoadjuvant chemotherapy for resectable colorectal liver metastasis with intermediate risk of postoperative recurrence: A multi-institutional retrospective study.
Noda T, Takahashi H, Tei M, Nishida N, Hata T, Takeda Y, Ohue M, Wada H, Mizushima T, Asaoka T, Uemura M, Kobayashi S, Murata K, Satoh T, Doki Y, Eguchi H; Clinical Study Group of Osaka University (CSGO), Colorectal Group, and Hepato‐Biliary‐Pancreatic Group. Noda T, et al. Ann Gastroenterol Surg. 2022 Oct 21;7(3):479-490. doi: 10.1002/ags3.12631. eCollection 2023 May. Ann Gastroenterol Surg. 2022. PMID: 37152774 Free PMC article.
214 results